日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of Proton Versus Photon Therapy for Medulloblastoma Using Updated Clinical Outcomes

基于最新临床结果的质子疗法与光子疗法治疗髓母细胞瘤的成本效益分析

Nantavithya, Chonnipa; Prayongrat, Anussara; Laohavinij, Wasin; Techavichit, Piti; Srilanchakon, Khomsak; Utoomprurkporn, Nattawan; Chantadisai, Maythinee; Wanlapakorn, Chaisiri; Shotelersuk, Kanjana

Combined clinical variable and radiomics of post-treatment total body scan for prediction of successful I-131 ablation in low-risk papillary thyroid carcinoma patients

结合临床变量和治疗后全身扫描的放射组学数据预测低风险乳头状甲状腺癌患者I-131消融治疗的成功率

Chantadisai, Maythinee; Wongwijitsook, Jirarot; Ritlumlert, Napat; Rakvongthai, Yothin

Dual-Tracer Parathyroid Imaging Using Joint SPECT Reconstruction

利用联合SPECT重建的双示踪剂甲状旁腺成像

Onwanna, Jaruwan; Chantadisai, Maythinee; Chaiwatanarat, Tawatchai; Rakvongthai, Yothin

Whole-body uptake classification and prostate cancer staging in (68)Ga-PSMA-11 PET/CT using dual-tracer learning

利用双示踪剂学习技术对 (68)Ga-PSMA-11 PET/CT 进行全身摄取分类和前列腺癌分期

Capobianco, Nicolò; Sibille, Ludovic; Chantadisai, Maythinee; Gafita, Andrei; Langbein, Thomas; Platsch, Guenther; Solari, Esteban Lucas; Shah, Vijay; Spottiswoode, Bruce; Eiber, Matthias; Weber, Wolfgang A; Navab, Nassir; Nekolla, Stephan G

Comparison of the Diagnostic Performance of Myocardial Perfusion Scintigraphy with and Without Attenuation Correction

比较有无衰减校正的心肌灌注显像的诊断性能

Vachatimanont, Sira; Sirisalipoch, Sasitorn; Chantadisai, Maythinee

Pretherapeutic Comparative Dosimetry of (177)Lu-rhPSMA-7.3 and (177)Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer

转移性去势抵抗性前列腺癌患者治疗前(177)Lu-rhPSMA-7.3和(177)Lu-PSMA I&T的比较剂量学研究

Feuerecker, Benedikt; Chantadisai, Maythinee; Allmann, Anne; Tauber, Robert; Allmann, Jakob; Steinhelfer, Lisa; Rauscher, Isabel; Wurzer, Alexander; Wester, Hans-Jürgen; Weber, Wolfgang A; d'Alessandria, Calogero; Eiber, Matthias

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results

使用 (177)Lu-FAP-2286 进行肽靶向放射性核素治疗多种腺癌的可行性、生物分布和初步剂量测定:首次人体试验结果

Baum, Richard P; Schuchardt, Christiane; Singh, Aviral; Chantadisai, Maythinee; Robiller, Franz C; Zhang, Jingjing; Mueller, Dirk; Eismant, Alexander; Almaguel, Frankis; Zboralski, Dirk; Osterkamp, Frank; Hoehne, Aileen; Reineke, Ulrich; Smerling, Christiane; Kulkarni, Harshad R

Pharmacokinetic Modeling of (18)F-FDOPA PET in the Human Brain for Early Parkinson's Disease

早期帕金森病人脑中 (18)F-FDOPA PET 的药代动力学模型

Buratachwatanasiri, Wirunpatch; Chantadisai, Maythinee; Onwanna, Jaruwan; Chongpison, Yuda; Rakvongthai, Yothin; Khamwan, Kitiwat